Neoleukin Therapeutics, Inc.
SEC Filing List
NLTX CIK: 0001404644
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Cvijic Christine Mikail | Neurogene Inc. | 07/07/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Neurogene Inc. | Workiva Inc. Wdesk FA01 /fa | 07/02/2026 | |
| 8-K | Current report filing | Neurogene Inc. | 07/02/2026 | ||
| 4 | Statement of changes in beneficial owner... | Cvijic Christine Mikail | Neurogene Inc. | 07/02/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Neurogene Inc. | Workiva Inc. Wdesk FA01 /fa | 06/30/2026 | |
| 8-K | Current report filing | Neurogene Inc. | 06/29/2026 | ||
| 4/A | Amendment to Statement of changes in ben... | Woods Keith | Neurogene Inc. | 06/16/2026 | |
| 4/A | Amendment to Statement of changes in ben... | Woods Keith | Neurogene Inc. | 06/16/2026 | |
| 4/A | Amendment to Statement of changes in ben... | Woods Keith | Neurogene Inc. | 06/16/2026 | |
| 3/A | Amendment to the Initial statement of be... | Woods Keith | Neurogene Inc. | 06/16/2026 | |
| No record found. | |||||
| Load More | |||||
